Bulletin
Investor Alert

New York Markets Open in:

Gain Therapeutics Inc.

NAS: GANX

GO
/marketstate/country/us

Market closed

/zigman2/quotes/225456774/composite

$

3.20

Change

-0.01 -0.31%

Volume

Volume 18,210

Sep 26, 2023, 3:59 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/225456774/composite

Previous close

$ 3.21

$ 3.20

Change

-0.01 -0.31%

Day low

Day high

$3.12

$3.25

Open
Open: 3.25

52 week low

52 week high

$2.80

$6.19

Open

Market cap

$40.77M

Average volume

34,230

P/E ratio

N/A

Rev. per Employee

$1,724

EPS

-1.83

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/ganx

MarketWatch News on GANX

  1. Gain Therapeutics started at buy with $10 stock price target at Maxim Group

    8:51 a.m. Sept. 12, 2023

    - Tomi Kilgore

  2. Gain Therapeutics downgraded to neutral from buy at B. Riley

    10:30 a.m. Aug. 19, 2022

    - Tomi Kilgore

  3. Gain Therapeutics stock price target cut to $11 from $16 at B. Riley

    7:23 a.m. May 23, 2022

    - Tomi Kilgore

  4. Gain Therapeutic stock price target cut to $16 from $21 at B. Riley

    7:52 a.m. March 29, 2022

    - Tomi Kilgore

  5. Gain Therapeutics started at buy with $21 stock price target at B. Riley

    9:39 a.m. Nov. 3, 2021

    - Tomi Kilgore

  6. Gain Therapeutics started at outperform with $30 stock price target at Oppenheimer

    8:04 a.m. April 12, 2021

    - Tomi Kilgore

  7. Gain Therapeutics started at buy with $30 stock price target at BTIG

    6:28 a.m. April 12, 2021

    - Tomi Kilgore

/news/nonmarketwatch/company/us/ganx

Other News on GANX

/news/pressrelease/company/us/ganx

Press Releases on GANX

  1. Sidoti's January Micro-Cap Conference

    11:01 a.m. Jan. 17, 2023

    - ACCESSWIRE

Rates »

Link to MarketWatch's Slice.